This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2019 Nov;20(7-8):630.

doi: 10.1080/21678421.2019.1639381. Epub 2019 Jul 14.

No authors listed

Published Erratum

No authors listed. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov.

. 2019 Nov;20(7-8):630.

doi: 10.1080/21678421.2019.1639381. Epub 2019 Jul 14.

No abstract available

A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis.
Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS Study Group. Shefner JM, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1-11. doi: 10.1080/21678421.2019.1612922. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31081694 Clinical Trial.